Funding options for ambitious growth companies



Funding options for ambitious growth companies


DATE: 2 October 2018
TIME: 18:00 - 20:30
VENUE: Hotel du Vin, Cambridge

The evening’s topic is funding, with discussion to cover a range of funding options open to ambitious companies at various stages of revenue and growth.  Our guest speaker is Nooman Haque, Managing Director of Life Sciences & Healthcare at Silicon Valley Bank UK.  Nooman leads a team dedicated to supporting early, growth stage and established businesses across all sectors of life sciences.

Joining Nooman as an expert witness will be Andrew Muncey, CFO at Artios Pharma Ltd. Andrew has over 30 years’ experience in finance and has helped Biotech companies raise in excess of $400m of equity in recent years. The companies include Artios Pharma, Bicycle Therapeutics, Kymab, Mission Therapeutics and PhoreMost. Andrew is currently Chief Financial Officer at Artios Pharma.

The Life Sciences Dinner is hosted by Bailey Fisher Executive Search in partnership with Silicon Valley Bank and Taylor Wessing.

Attendance at this dinner is by invitation for CEOs & CFOs in growth companies within life sciences.

Share Button